AI Generated
Sep 3, 2026, 15:37
Hadis Nabipoor: QICL2026 Highlights the Critical Importance of Transfusion Safety
Hadis Nabipoor, Medical Laboratory Scientist at Borhan Pathobiology Lab, shared a post on LinkedIn:
”Allogeneic transfusion saves lives, but it’s not without risk — from ABO incompatibility to transfusion-related immunomodulation.
As highlighted at QICL2026, patient safety must remain the core of every step in the transfusion medicine process.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 15:32Gopal Patidar: The ISBT Haemovigilance Working Party Sharing Knowledge and Promoting Best Practices
-
Sep 3, 2026, 15:24Bhalchandra Kawdikar: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 15:18Massimo Martino: Redefining Allogeneic Transplantation in Myelofibrosis
-
Sep 3, 2026, 15:10Tvisha Subhasish: Extravascular Factor IX Beyond the Circulation
-
Sep 3, 2026, 11:21Thrombotic Microangiopathies: From Clinical Syndrome to Molecularly Targeted Therapy
-
Sep 3, 2026, 10:56Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?
-
Sep 3, 2026, 10:42Jared Griffard: Hemorrhagic Shock and Component Blood Transfusion
-
Sep 3, 2026, 10:31Alan Nurden: Comparing Antiplatelet and Antithrombin Therapies in Coronary Microcirculation
-
Sep 3, 2026, 08:53Jamie’s Journey Through a Decade with Immune Thrombocytopenia – ITP Support Association